Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 11;21(18):6646.
doi: 10.3390/ijms21186646.

Milk Exosomes: Perspective Agents for Anticancer Drug Delivery

Affiliations
Free PMC article
Review

Milk Exosomes: Perspective Agents for Anticancer Drug Delivery

Sergey Sedykh et al. Int J Mol Sci. .
Free PMC article

Abstract

Exosomes are biological nanovesicles that participate in intercellular communication by transferring biologically active chemical compounds (proteins, microRNA, mRNA, DNA, and others). Due to their small size (diameter 40-100 nm) and high biological compatibility, exosomes are promising delivery tools in personalized therapy. Because artificial exosome synthesis methods are not developed yet, the urgent task is to develop an effective and safe way to obtain exosomes from natural sources. Milk is the only exosome-containing biological fluid that is commercially available. In this regard, milk exosomes are unique and promising candidates for new therapeutic approaches to treating various diseases, including cancer. The appearance of side effects during the use of cytotoxic and cytostatic agents is among the main problems in cancer chemotherapy. According to this, the targeted delivery of chemotherapeutic agents can be a potential solution to the toxic effect of chemotherapy. The ability of milk exosomes to carry out biologically active substances to the cell makes them promising tools for oral delivery of chemotherapeutic agents. This review is devoted to the methods of milk exosome isolation, their biological components, and prospects for their use in cancer treatment.

Keywords: cancer; drug delivery; exosomes; isolation; milk; milk exosomes; vesicles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Cintio M., Polacchini G., Scarsella E., Montanari T., Stefanon B., Colitti M. MicroRNA Milk Exosomes: From Cellular Regulator to Genomic Marker. Animals. 2020;10:1126. doi: 10.3390/ani10071126. - DOI - PMC - PubMed
    1. Colombo M., Raposo G., Théry C. Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 2014;30:255–289. doi: 10.1146/annurev-cellbio-101512-122326. - DOI - PubMed
    1. Sawada S.I., Sato Y.T., Kawasaki R., Yasuoka J.I., Mizuta R., Sasaki Y., Akiyoshi K. Nanogel hybrid assembly for exosome intracellular delivery: Effects on endocytosis and fusion by exosome surface polymer engineering. Biomater. Sci. 2020;8:619–630. doi: 10.1039/C9BM01232J. - DOI - PubMed
    1. Bunggulawa E.J., Wang W., Yin T., Wang N., Durkan C., Wang Y., Wang G. Recent advancements in the use of exosomes as drug delivery systems. J. Nanobiotechnol. 2018;16:81. doi: 10.1186/s12951-018-0403-9. - DOI - PMC - PubMed
    1. Admyre C., Johansson S.M., Qazi K.R., Filén J.-J., Lahesmaa R., Norman M., Neve E.P.A., Scheynius A., Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007;179:1969–1978. doi: 10.4049/jimmunol.179.3.1969. - DOI - PubMed

LinkOut - more resources